250 & 290 Binney Street
Update
04/29/22
AstraZeneca to Move Open Kendall Square Research HQ
Drug manufacturer AstraZeneca has announced it will open a research headquarters at 250 & 290 Binney Street in Cambridge's Kendall Square. The company will move its Waltham division and subsidiary Alexion to the new building development. Part of the master-planned MXD District, the 250 & 290 Binney Street project call for 857,000+ SF of lab space across two 250-foot towers in Kendall Square.
Search BLDUP
Search
BLDUP
for news, projects, and companies to find the information that pushes your business forward.
